|
Allen, Peter J |
Duke University |
Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Cao, Yin |
Washington University |
Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia |
|
PA-19-056: Research Project Grant |
|
Chak, Amitabh |
Case Western Reserve University |
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma |
Barrett's Esophagus Translational Research Network |
PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
|
Chan, Andrew T |
Massachusetts General Hospital |
Precision Prevention Research Program |
|
PAR-19-349: NCI Outstanding Investigator Award |
|
Chan, Andrew T |
Massachusetts General Hospital |
Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Chang, Su-Hsin |
Washington University |
Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective |
|
PAR-19-279: Provocative Questions (PQs) in Multiple Myeloma Disparities Research |
|
Chung, Raymond T |
Massachusetts General Hospital |
Trial of Statins for Chemoprevention in Hepatocellular Carcinoma |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
El-Serag, Hashem B |
Baylor College Of Medicine |
Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome |
|
PAR-20-077: National Cancer Institute Program Project Applications |
|
Katona, Bryson William |
University Of Pennsylvania |
Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants |
|
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
|
Lipkin, Steven M |
Weill Medical Coll Of Cornell Univ |
(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance |
|
RFA-CA-17-017: Research Answers to NCI's Provocative Questions |
|
Malafa, Mokenge P |
H. Lee Moffitt Cancer Ctr & Res Inst |
Novel Therapy to Inhibit IPMN Progression |
|
PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program |
|
Markowitz, Sanford D. |
Case Western Reserve University |
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment |
|
PAR-15-342: NCI Outstanding Investigator Award |
|
Moyer, Matthew T. |
Pennsylvania State Univ Hershey Med Ctr |
CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial |
|
PA-16-160: NIH Research Project Grant |
|
Schmit, Stephanie L |
Cleveland Clinic Lerner Com-Cwru |
Variation in tumor-associated immune profiles and colorectal cancer outcomes |
|
PAR-18-654: Basic Research in Cancer Health Disparities |
|
Ulrich, Cornelia M. |
University Of Utah |
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link |
|
PA-20-185: NIH Research Project Grant |
